Methylation of a newly identified region of the INS-IGF2 gene determines IGF2 expression in breast cancer tumors and in breast cancer cells.

Radhakrishnan, Vinodh Kumar; Ravichandran, Kameswaran; Eke, Chibuzo; Ortiz-Vicil, Amanda; Tan, Qianwei; León, Marino De; León, Daisy D De

Radhakrishnan, Vinodh Kumar; Ravichandran, Kameswaran; Eke, Chibuzo; Ortiz-Vicil, Amanda; Tan, Qianwei; León, Marino De; León, Daisy D De.

Afiliação

Radhakrishnan VK; Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
Ravichandran K; Division of Renal Diseases and Hypertension, University of Colorado at Denver, Aurora, CO 80045, USA.
Eke C; Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
Ortiz-Vicil A; Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
Tan Q; Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
León M; Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
León DD; Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.

Oncotarget ; 11(44): 3904-3920, 2020 Nov 03.

Article em En | MEDLINE | ID: mdl-33216823

Palavras-chave

DMR; IGF2; INS-IGF2; epigenetics; hypermethylation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google